cetuximab [clinicaltrials_resource:de436afd4272b3a4a6c5f3eb7eb2657e]
intervention [clinicaltrials_vocabulary:intervention]
cetuximab [clinicaltrials_resource:de436afd4272b3a4a6c5f3eb7eb2657e]
Bio2RDF identifier
de436afd4272b3a4a6c5f3eb7eb2657e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:de436afd4272b3a4a6c5f3eb7eb2657e
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
400 mg/m2 first dose then weekly at 250 mg/m2 until disease progression
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:de436afd4272b3a4a6c5f3eb7eb2657e
title
cetuximab
@en
type
label
cetuximab [clinicaltrials_resource:de436afd4272b3a4a6c5f3eb7eb2657e]
@en